Enlivex ENLV
NASDAQ ENLV
$0.42 -0.08 (-15.93%)
At close: Oct 1, 2026 · 4:00 PM EDT

Enlivex (ENLV) Interest Expenses (2013 - 2015)

Updated

Enlivex (ENLV) reported Interest Expenses of -$55,000 for Q2 2015, compared with $2,000 a year earlier.

Analysis

Enlivex (ENLV) Interest Expenses (2013 - 2015) Analysis & Trends

Over the twelve months ended Jun 30, 2015, Enlivex's Interest Expenses came in at -$140,000; for FY2014, it came in at -$58,000.

  • By year, Interest Expenses came in at -$3,000 in FY2013 and $3,000 in FY2012.
  • The Q2 2015 figure ranks as the lowest quarterly Interest Expenses in data going back to Q3 2013.
  • Per Business Quant data, the three quarters before Q2 2015 came in at -$21,000 (Q1 2015), -$45,000 (Q4 2014) and -$19,000 (Q3 2014).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Enlivex 1.52 Mn -54.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 -55,000.00
Mar 31, 2015 -21,000.00
Dec 31, 2014 -45,000.00
Sep 30, 2014 -19,000.00
Jun 30, 2014 2,000.00
Mar 31, 2014 4,000.00
Dec 31, 2013 -7,000.00
Sep 30, 2013 3,000.00
API Access

Enlivex Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ENLV&period=max&api_key=YOUR_API_KEY